Home » Topics » Regulatory

Regulatory
RSS

Nivolumab, the first drug targeting PD-1 approved

July 7, 2014

Japanese approval of Alecensa for ALK-positive NSCLC

July 7, 2014

FDA approves belinostat for peripheral T-cell lymphoma

July 4, 2014

FDA approves inhaled insulin for type 1 diabetes

June 30, 2014

FDA approves oral and intravenous tedizolid phosphate for bacterial skin infections

June 23, 2014

FDA approves Lymphoseek for use in head and neck cancer

June 16, 2014

FDA approves Eloctate for hemophilia A

June 10, 2014

FDA approves Omidria for use in cataract and intraocular lens replacement procedures

June 3, 2014

FDA approves dalbavancin for bacterial skin and skin structure infections

May 26, 2014

Empagliflozin approved in E.U.

May 23, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 3, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 3, 2025.
Researchers arm CAR T cells to fight solid tumors
BioWorld
Aussie researchers have used CRISPR gene editing tools to “armor” chimeric antigen receptor (CAR) T cells to activate additional cancer-fighting proteins at the...
Bioversys, Shionogi in CHF529M lung infection collaboration
BioWorld Science
Antibiotics specialist Bioversys AG has sealed a potential CHF529 million (US$667.5 million) deal with Shionogi Co. Ltd., in which they will work together on...
Medtronic receives CE mark for its Vitalflow ECMO system
BioWorld MedTech
Medtronic plc received a CE mark for its Vitalflow extracorporeal membrane oxygenation (ECMO) system, which provides temporary support for the heart and lungs in...